Cargando…
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs
The primary purpose of this study was to assess the translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system (CNS) active drugs. As a part of this, IBs were reviewed on reporting quality. Investigator’s Brochures (IBs) of studies...
Autores principales: | Ferreira, Guilherme S., Dijkstra, Francis M., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Schellekens, Huub, Moors, Ellen H. M., van Meer, Peter J. K., Stuurman, Frederik E., van Gerven, Joop M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977891/ https://www.ncbi.nlm.nih.gov/pubmed/36859342 http://dx.doi.org/10.1038/s41398-023-02353-1 |
Ejemplares similares
-
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development
por: Ferreira, Guilherme S., et al.
Publicado: (2019) -
A standardised framework to identify optimal animal models for efficacy assessment in drug development
por: S. Ferreira, Guilherme, et al.
Publicado: (2019) -
Levelling the Translational Gap for Animal to Human Efficacy Data
por: Ferreira, Guilherme S., et al.
Publicado: (2020) -
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers
por: Dijkstra, Francis, et al.
Publicado: (2022) -
The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)